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Abstract
Background: Alveolar macrophages are sentinels of the pulmonary mucosa and
central to maintaining immunological homeostasis. However, their role in govern-
ing the response to allergen is not fully understood. Inappropriate responses to
the inhaled environment manifest as asthma.
Methods: We utilized a mechanistic IL-13-driven model and a house dust mite aller-
gen mucosal sensitization model of allergic airway disease to investigate the role of
alveolar macrophages in regulating pulmonary inflammation.
Results: IL-13-dependent eosinophilic and Th2 inflammation was enhanced in
mice depleted of alveolar macrophages using clodronate liposomes. Similarly,
depletion of alveolar macrophages during house dust mite sensitization or estab-
lished disease resulted in augmented Th2 immunity and increased allergen-specific
IgG1 and IgE. Clodronate treatment also delayed the resolution of tissue inflam-
mation following cessation of allergen challenge. Strikingly, tissue interstitial mac-
rophages were elevated in alveolar macrophage-deficient mice identifying a new
homeostatic relationship between different macrophage subtypes. A novel role for
the macrophage-derived immunoregulatory cytokine IL-27 was identified in mod-
ulating Th2 inflammation following mucosal allergen exposure.
Conclusions: In summary, alveolar macrophages are critical regulators of Th2
immunity and their dysregulation promotes an inflammatory environment with
exacerbation of allergen-induced airway pathology. Manipulating IL-27 may pro-
vide a novel therapeutic strategy for the treatment of asthma.
Allergic asthma is a chronic inflammatory disease which has
traditionally been attributed to atopy, eosinophilia, and
excessive Th2 mediators (1). However, clinical trials to target
pro-inflammatory Th2 pathways have had limited success (2–
4). Alveolar macrophages (AMs) are thought to play a cen-
tral role in maintaining immunological homeostasis and host
defense in the lung (5–8). Critical to their function, they are
situated in the airway lumen, in close proximity to the muco-
sal surface where typically, they are the first immune cell to
encounter the myriad particles that are contained within the
inhaled environment. Human studies have demonstrated that
the frequency of AMs in asthmatics and healthy individuals
is comparable (9); however, some functionality may be
altered in disease. AMs retrieved from asthmatics induce
higher levels of IL-5 from T-lymphocyte co-cultures com-
pared to those from nonatopic individuals (10). Additionally,
AMs from pediatric asthmatics have impaired phagocytic
ability and demonstrate greater apoptosis (11). In experimen-
tal systems, prior allergen exposure renders the lungs more
susceptible to bacterial infection through desensitization of
toll-like receptors (TLRs) and upregulation of endogenous
negative regulators of TLR signalling expressed by AMs (12).
Furthermore, GM-CSF, a mediator known to be upregulated
in asthmatic bronchial epithelium (13), has been shown to
inhibit the suppressive capacity of alveolar macrophages in
animal studies (14, 15). Thus, it is possible that the
development of asthma, its lack of resolution, and associated
exacerbations may be intimately linked with a breakdown in
AM-mediated homeostasis.
Although inappropriate responses to airborne antigens are
thought to contribute to the chronic inflammatory environ-
ment observed in asthma, the particular role that AMs play
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in controlling these responses is not well understood. Experi-
mental studies utilizing rodents sensitized peripherally with
OVA and the adjuvant alum prior to aerosolized OVA chal-
lenge have shown that depletion of AMs prior to challenge
results in exacerbation of airway hyper-reactivity (16–19).
However, AMs are resident within the airway mucosa and
sample the inhaled environment; thus, peripheral sensitization
models do not mimic how these cells encounter allergen in
human disease. We have investigated the role of AMs at dis-
ease inception, during established inflammation and in pro-
moting resolution of allergic airways disease (AAD) induced
by repeated intranasal administration of house dust mite
extract (HDM)—a clinically relevant allergen to which 50–
85% of asthmatics are allergic to (20). We demonstrate that
AMs are necessary to regulate mucosal sensitization to
inhaled allergen. The macrophage-derived immune-regulatory
cytokine IL-27 is implicated in maintaining pulmonary
homeostasis. Moreover, evidence of a novel interaction
between alveolar and interstitial macrophages was
demonstrated. By identifying deficiencies in pulmonary
defense and homeostatic mechanisms, we may be able to
intervene to promote efficient resolution of inflammation and
restore immune pulmonary homeostasis.
Methods
Female BALB/c mice (Charles River, Bicester, UK) 6–
8 weeks old received intratracheal administration of either
IL-13 (5 lg; Gibco, Frederick, MD, USA) or vehicle (PBS +
1% FCS) on three consecutive days. Mice receiving lipo-
somes were dosed 2 days prior to the first IL-13 administra-
tion and killed 15 h after the last administration.
Additionally, mice received either 25 lg HDM extract Der-
matophagoides pteronyssinus (Greer Laboratories, Lenoir,
NC, USA) or PBS via intranasal instillation, 3 times per
week for three weeks. Mice were killed either 4 h or 7 or
13 days postfinal HDM instillation. 50-ll liposome-encapsu-
lated clodronate or PBS was administered intratracheally
either once weekly, commencing 2 days prior to HDM expo-
sure (sensitization phase) or twice during the final week of
HDM exposure (challenge phase) or 1 and 5 days after the
last HDM challenge (resolution phase). All mice were housed
in specific pathogen-free conditions and provided food and
water ad libitum. All experiments were performed in accor-
dance with the UK Animals (Scientific Procedures) Act 1986.
Serum, bronchoalveolar lavage (BAL), lung tissue, and
lung cells were collected. Differential counts were performed
on Wright-Geimsa (Sigma, Poole, UK)-stained cytospins.
Disaggregated lung and BAL cells were stained with
CD45, CD3, CD4, Siglec F, Gr-1, CD11c, CD11b (BD Bio-
sciences, Oxford, UK), T1/ST2 (MD Biosciences, St. Paul,
MN, USA), MOMA2, CD68 (AbD Serotec, Kidlington,
UK) and F4/80 (eBiosciences, Hatfield, UK), or relevant iso-
type controls for 20 min at 4°C. Fixed cells were analyzed on
a FACSCalibarTM using CellQuest (BD Biosciences).
Lung tissue supernatant and BAL were analyzed by
ELISA; IL-4, IL-5 and IL-10 (PharMingen, Oxford, UK),
IL-13 (eBioscience) and IL-27 (R&D systems, Abingdon,
UK), or ultra-sensitive MSD kits (Meso Scale Discovery,
Rockville, MD, USA). Paired antibodies for IgE and IgG1
(R&D systems) were used to measure serum Ig levels.
Tissue lipids were extracted, and lipoxin A4 was quantified
by LC/MS/MS.
F4/80+ CD11c+ AMs and F4/80+ CD11c- interstitial mac-
rophages were cell-sorted from lung tissue and BALF. RNA
was extracted and IL-27 levels determined by qPCR using
specific primers (Applied Biosystems, Paisley, UK).
Additional details on the methods utilized in this study are
provided in the Supporting Information (Data S1).
Data were analyzed using Prism 5 (GraphPad Software
Inc., La Jolla, CA, USA). Data are expressed as single data
points with bars representing group medians, unless other-
wise stated. A two-tailed P value was determined by the
Mann–Whitney U-test when comparing between 2 groups.
Data shown represent means  SEM of at least 2 indepen-
dent experiments (n = 8–16).
Results
IL-13-induced Th2 airway pathology is amplified following
the depletion of alveolar macrophages
To assess the role of AMs in the development of mucosal
Th2 immunity, a short-term model of IL-13-induced lung
inflammation was employed (21, 22) in macrophage-replete
mice and animals devoid of AMs. Clodronate liposomes
administered 2 days prior to IL-13 instillation (Fig. 1A)
resulted in 80% depletion of AMs in BAL (Fig. 1B), without
affecting tissue-resident interstitial macrophages (Fig. S1).
The proinflammatory effects of IL-13 were amplified in the
absence of AMs, demonstrated by increased accumulation of
eosinophils, neutrophils, and Th2 cells in BAL (Fig. 1C–F).
In addition, BAL IL-4 and IL-5 levels were elevated in AM-
depleted mice (Fig. 1G and H), although no enhancement of
IL-10 was observed (Fig S2). These data suggest a protective
role for AMs against development of Th2 immunity.
The absence of alveolar macrophages augments HDM-
induced airway Th2 inflammation
To explore the role of AMs during allergen sensitization and
the development of AAD, clodronate was administered prior
to HDM exposure and throughout the allergen sensitization
period. AMs were also depleted during the final week of
allergen challenge to investigate the role of AMs in perpetu-
ating established AAD (Fig. 2A).
House dust mite exposure increased accumulation of eosin-
ophils, neutrophils and Th2 cells, and Th2 cytokines includ-
ing IL-4, IL-5, and IL-10 in the BAL (Fig. 2B–H). Depletion
of AMs prior to allergen sensitization or during challenge
significantly exacerbated HDM-induced lung inflammation.
The number of BAL leukocytes in clodronate-treated mice
was at least twofold greater than in HDM-exposed mice
receiving control liposomes (Fig. 2B). The absence of AMs
resulted in increased numbers of both eosinophils and neu-
trophils (Fig. 2C and D). Concomitant with the enhanced
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Figure 1 IL-13-induced Th2 airway pathology is amplified following
the depletion of alveolar macrophages (A) Schematic depicting
either PBS or clodronate (Clod) liposome and IL-13 administration
protocol. Mice received either clodronate-containing liposomes
(Clod) or PBS-containing liposomes (PBS). 48 hours later, mice
received either 5 lg of IL-13 or PBS + 1% FCS (vehicle) for 3 con-
secutive days. Mice were culled 15 h later. (B) alveolar macrophag-
es (C) total airway leukocytes (D) eosinophils (E) neutrophils (F) Th2
lymphocytes retrieved following broncho-alveolar lavage and quanti-
fied by flow cytometry. BAL fluid was analyzed for inflammatory
cytokines by ELISA (G) IL-4 and (H) IL-5. *P < 0.05 and **P < 0.01
relative to PBS control group by Mann–Whitney U-test, n = 6–8.
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eosinophilia, eotaxin1/CCL11 was also increased in the BAL
in the absence of AMs (Fig. S3A). In contrast, the neutrophil
chemoattractant, KC/CXCL1, was only elevated when AMs
were depleted during HDM challenge (Fig. S3B). In addition,
AM deficiency during the sensitization or challenge phases
significantly increased the number of Th2 cells in BAL
(Fig. 2E). However, exaggerated production of the Th2 cyto-
kines IL-4 and IL-5 was only observed when AMs were
depleted during allergen challenge (Fig. 2F and G). No
changes in HDM-induced IL-13 were detected (data not
shown). Surprisingly, depletion of AMs during HDM
sensitization or challenge further enhanced HDM-induced
production of IL-10, IL-12, and IFNc (Fig. 2H and S3C and
D). These findings indicate AMs are important for regulating
the pulmonary immune response to inhaled allergen in the
airways.
Alveolar macrophage depletion influences the leukocyte
composition of lung tissue and augments systemic immune
responses following mucosal HDM exposure
Depletion of AMs during either allergen sensitization or chal-
lenge significantly increased the number of tissue leukocytes
recruited to the lung in response to HDM exposure
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Figure 2 The absence of alveolar macrophages during mucosal
allergen sensitization and challenge augments house dust mite-
induced Th2 inflammation in the airways (A) Schematic depicting
either PBS or clodronate (Clod) liposome and house dust mite
(HDM) administration. (B) Total airway leukocytes, (C) eosinophils,
(D) neutrophils, and (E) Th2 lymphocytes retrieved following bronc-
hoalveolar lavage and quantified by flow cytometry. BAL fluid was
analyzed for inflammatory cytokines by ELISA (F) IL-4, (G) IL-5, and
(H) IL-10. *P < 0.05, **P < 0.01, and ***P < 0.001 relative to PBS
control group by Mann–Whitney U-test, n = 6–8.
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(Fig. 3A). Tissue-resident interstitial macrophages have also
been proposed to play a key role in maintaining immune
homeostasis in the respiratory tract (23). Therefore, it was
important to verify that this population of macrophages was
not eliminated by the clodronate treatment. AM depletion
actually increased the number of interstitial macrophages in
response to HDM (Fig. 3B and C), which was coincident
with elevated levels of IL-10 (Fig. 2H). Thus, the augmenta-
tion of Th2 airway pathology in HDM-exposed clodronate-
treated mice is not due to the deletion of regulatory tissue
interstitial macrophages.
The absence of AMs during HDM sensitization specifically
enhanced the systemic Th2 antibody response. Total IgE and
HDM-specific IgE and IgG1 were significantly elevated in
HDM-exposed mice pretreated with clodronate liposomes
(Fig. 3D–F), whereas HDM-specific IgG2a was not modu-
lated (Fig. 3G). The absence of AMs in the respiratory tract
has far-reaching consequences both in the lung parenchyma
and on systemic Th2 responses following allergen exposure.
Alveolar macrophages are elevated concomitant with the
resolution of HDM-induced inflammation
We next sought to ascertain whether AMs play an active role
in the resolution of HDM-induced AAD. Mediators of
allergic disease were measured 7 and 13 days after the last
allergen challenge and compared to peak inflammation, 4 h
post-HDM (Fig. 4A). HDM-induced inflammation remained
significantly elevated 7 days postfinal challenge and resolved
to baseline levels by 13 days (Figs 4B and S4A). Tissue eo-
sinophils remained at least threefold higher at 7 days, resolv-
ing by 13 days (Fig. 4C). In the BAL, inflammation was also
predominantly eosinophilic. Numbers were significantly
reduced by 13 days, but some residual eosinophils remained
(Fig. S4B). HDM-induced neutrophilia, evident at peak
inflammation, resolved more rapidly and returned to baseline
by 7 days (Figs 4D and S4C). HDM-induced Th2 lympho-
cytes and IL-5 and IL-13 levels remained elevated 7 days
post-HDM and resolved by day 13 (Fig. 4E–G). Lipoxin A4
was induced following HDM exposure, and elevated levels
were measured throughout the resolution time course indicat-
ing that lipoxin A4 is involved in the active resolution of
inflammation (Fig. 4H). FoxP3+ T-regulatory cells remained
significantly elevated at 7 days and returned to baseline levels
by 13 days after the final allergen exposure (Fig. 4I). AMs
were significantly elevated following cessation of allergen
challenge (Fig. 4J) implying that these cells play an active
role in directing the return to pulmonary homeostasis.
Return to homeostasis is delayed following the removal of
alveolar macrophages
Alveolar macrophages were depleted during the resolution
phase (Fig. 5A), and parameters of airway inflammation
were assessed 14 days postfinal HDM exposure. Administra-
tion of clodronate liposomes during the resolution phase pre-
vented the clearance of HDM-induced airway inflammatory
cells (Fig. 5B). Eosinophilia, which resolves by day 14, was
not altered by macrophage depletion (Fig. 5C); however,
HDM-induced neutrophilia and Th2 cells failed to resolve in
the absence of AMs (Fig. 5D and E). No change in the pro-
file of IL-4, IL-5, or IL-13 levels was observed as a result of
depleting AMs during resolution (data not shown). However,
levels of KC/CXCL1 and MDC/CCL22 remained elevated at
14 days correlating with the neutrophil and T-cell numbers
in clodronate-treated mice (Fig. 5F), whereas eotaxin1/
CCL11 levels returned to baseline with resolution of eosino-
philia.
The interstitial macrophage population was not modulated
by exposure to HDM or AM depletion alone; however, num-
bers of pulmonary interstitial macrophages were increased in
HDM-exposed mice treated with clodronate during the reso-
lution phase. (Fig. 5G).
Exacerbation of HDM-induced disease is associated with
reduced levels of IL-27
We sought to determine whether immunoregulatory mediators
were modulated as a consequence of macrophage depletion.
TGF-b was not significantly altered following alveolar macro-
phage manipulation (data not shown), and we demonstrated
elevated IL-10 levels (Fig. 2H). Thus, we hypothesized that
there may be a role for the myeloid-derived, immunoregulatory
cytokine IL-27 in our models. To confirm AMs were a source
of IL-27, we analyzed FACS-sorted cells and demonstrated the
expression of IL-27 in this population (Fig. 6A).
In the lung tissue, levels of IL-27 were upregulated in
response to IL-13 or repeated HDM exposure (Fig. 6B and
C). Interestingly, the depletion of AMs also increased base-
line levels of IL-27 in nonallergic mice. However, clodronate
treatment during the sensitization phase resulted in a reduc-
tion of HDM-induced IL-27 concomitant with exacerbation
of Th2 pathology. Depletion of AMs during the resolution
phase did not modulate tissue levels of IL-27 which return to
baseline by 14 days. These data demonstrate that AMs are a
source of IL-27 and suggest a specific temporal role for IL-
27 in regulating Th2 responses at mucosal surfaces.
Discussion
This work characterizes for the first time the immunomodula-
tory role of AMs in a model of inhaled allergen-induced
AAD. It is evident that AMs are critical for the maintenance
of pulmonary homeostasis and disruption of this axis results
in uncontrolled Th2 inflammation in response to HDM and
IL-13. We also show that AMs drive the resolution of
inflammation following allergen challenge. In healthy individ-
uals, the primary role of AMs is in maintaining or restoring
homeostasis; however, in asthmatics, inappropriate or insuffi-
cient AM activity may perpetuate chronic inflammation by
lowering the immune activation threshold.
Activation of mucosal epithelial cells in response to inhaled
particulates can lead to the infiltration of granulocytes, which
release harmful cytotoxic mediators intended to protect host
tissues; however, left unchecked, these are potentially delete-
rious to the local microenvironment (24). Thus, granulocyte
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accumulation warrants tight regulation to preserve tissue
integrity (25, 26). Signals from apoptotic granulocytes induce
their efferocytosis by local tissue macrophages (26), and our
data show that macrophages are essential to limit the accu-
mulation of eosinophils and neutrophils in response to HDM
exposure, promoting a return to tissue homeostasis.
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challenge (A) Total tissue leukocytes and (B) lung interstitial macro-
phages quantified by flow cytometry. (C) FACS plots depicting lung
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tive to PBS control group by Mann–Whitney U-test, n = 6–8.
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House dust mite-challenged mice-lacking AMs during the
sensitization phase had increased Th2 cell recruitment com-
pared to macrophage-replete mice. When clodronate was
administered during the HDM challenge phase, once
inflammation was established, Th2 immunity was also
augmented, with increased accumulation of Th2 cells within
the airways and elevated IL-4 and IL-5. Cytokines were
quantified 5 days and 24 h after the last clodronate treatment
in the sensitization and challenge protocols, respectively.
Thus, the dysregulation of Th2 cytokines following AM
depletion appears to be transient and wanes as AMs begin to
repopulate the airways. Our data corroborate the studies
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utilizing the OVA model in which augmented airway pathol-
ogy was observed following AM removal (17–19). However,
our work further demonstrates that AMs constrain granulo-
cyte and effector T-cell accumulation in response to inhaled
allergen exposure irrespective of prior sensitization. In addi-
tion, we have established a critical role for AMs during the
different stages of disease pathogenesis.
Our data demonstrate that the immune activation threshold
is reduced in the absence of AMs and that these cells limit
HDM-induced allergic inflammation during established dis-
ease suggesting that AMs maintain a regulatory phenotype
throughout acute HDM exposure. In contrast, adoptive trans-
fer of AMs from OVA-sensitized mice fails to restore homeo-
stasis compared to transfer of naive AMs (19). It was proposed
that OVA sensitization and challenge altered the phenotype of
AMs to produce inflammatory cytokines and lose their sup-
pressive capacity. However, ex vivo culture of allergen-sensi-
tized AMs were shown to downregulate their pro-
inflammatory phenotype and restore their homeostatic func-
tions when subsequently transferred (27, 28). This exploitation
of macrophage plasticity makes these cells an interesting
potential target for therapy (29).
We investigated the role of AMs in promoting resolution
and restoring homeostasis by depleting AMs after cessation of
HDM exposure. This resulted in delayed resolution of Th2
immunity, indicating that AMs are involved in the clearance of
T-cell infiltrates recruited to the lung as a result of allergen
exposure.
Augmented inflammation was apparent within the lung tis-
sue and airway lumen as a result of the loss of AM-directed
homeostasis. Perhaps unexpectedly, the number of interstitial
macrophages in lung tissue was significantly increased during
exacerbated AAD. This expansion of interstitial macrophages
following the depletion of AMs was apparent in all three
HDM protocols indicating a direct relationship between these
two regulatory macrophage cell types. Interstitial macrophages
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Figure 5 The return to homeostasis after allergen challenge is
disrupted following the removal of alveolar macrophages (A)
Schematic depicting PBS or clodronate (Clod) liposome adminis-
tration protocol following the induction of allergic airways dis-
ease. (B) airway leukocytes retrieved following broncho-alveolar
lavage and (C) tissue eosinophils; (D) tissue neutrophils deter-
mined by differential counting. (E) Lung tissue Th2 lymphocytes
quantified by flow cytometry. (F) lung tissue chemokines mea-
sured by ELISA. (G) interstitial macrophages determined by flow
cytometry, n = 3–6 mice/group, bar represents median. *P < 0.05
and **P < 0.01 relative to PBS control group by Mann–Whitney
U-test, n = 3–6.
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have been reported to regulate airway inflammation via TLR4-
dependent IL-10 secretion (23). Additionally, interstitial mac-
rophages have been shown to express high levels of eotaxin1/
CCL11 (30). HDM extract contains TLR4 agonists (31), and
enhanced levels of IL-10 and eotaxin1/CCL11 were apparent
in our studies concomitant with the increased number of inter-
stitial macrophages. This suggests that interstitial macrophage
functionality remains intact during exacerbated AAD and that
the regulation of this subset is impaired in the absence of AMs.
The role of interstitial macrophages remains unclear in the
context of asthma. Production of eotaxin1/CCL11 and IL-10
suggests they have the potential to exert a dual role in an aller-
gic setting and further investigation is required. From our
studies, we clearly demonstrate that an important axis exists
between airway and tissue macrophage subsets.
The potent effects of removing AMs led us to investigate
potential mediators responsible for this dysregulated
homeostasis. IL-27 is predominantly produced by macrophages
and dendritic cells. This cytokine is upregulated in steroid
refractory asthmatics (32) and has been shown to modulate air-
way hyper-reactivity via downregulation of glucocorticoid
receptor signalling in macrophages (32). IL-27 also dampens
Th2 cell polarization and cytokine production in na€ıve CD4+
T-cell cultures and ameliorates OVA-induced allergic inflam-
mation when administered in vivo (33). In the gut, IL-27 has
been shown to mediate intestinal epithelial cell barrier protec-
tion via transcriptional activation of anti-inflammatory and
antibacterial pathways (34). We demonstrate for the first time
that IL-27 is upregulated in the lung following the administra-
tion of either exogenous IL-13 or HDM and that AMs are a
source of this cytokine. These data demonstrate that IL-27 is a
macrophage-derived immune-regulatory mediator which regu-
lates the pulmonary mucosal response to allergen.
In summary, we show that AMs are integral in the regula-
tion of inflammatory responses to inhaled allergen. We also
show for the first time a direct relationship between airway
alveolar and tissue interstitial macrophage populations. Thus,
macrophages play a critical role in the maintenance and resto-
ration of homeostasis following allergen exposure at the air-
way mucosa.
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clodronate treatment.
A CB
Sorted alveolar
macrophages
IL
-2
7 
ex
pr
es
si
on
 r
el
at
iv
e 
to
 G
PD
H
Lu
ng
 IL
-2
7 
pg
/m
l
Lu
ng
 IL
-2
7 
pg
/m
l
0.0
0.2
0.4
0.6
0.8
0
20
30
40
10
0
20
40
60
80
100
PBS
Vehicle IL-13
Clod PBS Clod PBS
Sham HDM
Senstisation Resolution
14 days
HDM
Clod PBS Clod PBS Clod
* *
*
***
Figure 6 Exacerbation of IL-13- and HDM-induced disease follow-
ing alveolar macrophage depletion is associated with reduced lev-
els of the immuno-regulatory cytokine IL-27. IL-27 mRNA
expression in lung FACS-sorted macrophages analyzed by qPCR (A)
F4/80+ CD11c+ alveolar macrophages, (B) IL-13-treated mice, and
(C) HDM-treated mice with alveolar macrophage depletion during
sensitization and during resolution *P < 0.05 and **P < 0.01 rela-
tive to PBS control group by Mann–Whitney U-test, n = 5–8.
Allergy 70 (2015) 80–89 © 2014 The Authors. Allergy Published by John Wiley & Sons Ltd.88
Macrophages are sentinels of pulmonary homeostasis Mathie et al.
Figure S2. IL-10 levels are not modulated in response to
IL-13 and are unaffected by macrophage depletion.
Figure S3. Alveolar macrophage depletion augments house
dust mite induced chemokine and cytokine secretion.
Figure S4. Resolution of inflammation following cessation
of allergen challenge.
Data S1. Materials and methods.
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